NCT04626843 2023-02-14
Intermittent Fasting and CLL/SLL
British Columbia Cancer Agency
Phase 1 Completed
Clinical Trials
5 trialsNCT02229201 2014-09-01
Comparison of Two Anaesthetics on Brain During Brain Tumour Surgery
University Medical Centre Ljubljana
Phase 1 Completed
NCT01089998 2013-01-21
PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Safety and Tolerability in Healthy Volunteers and Safety, Tolerability and Diagnostic Performance of BAY86-9596 in Patients With Non-small Cell Lung Cancer, Breast Cancer, Head and Neck Cancer and Patients With Inflammations
Life Molecular Imaging SA
Phase 1 Completed
NCT01297088 2013-01-21
PET/CT (Positron Emission Tomography / Computed Tomography) Investigations With BAY86-9596 (18F) (300 MBq) Following Single Intravenous Administration in Patients With Cancer or Inflammations.
Life Molecular Imaging SA
Phase 1 Completed
NCT00817752 2010-03-18
Ashwagandha: Effects on Stress, Inflammation and Immune Cell Activation
National University of Natural Medicine
Phase 1 Completed